We find that the deletion of either Notch1 or Notch2 in the BlgCre Pten p53 background resulted in a dose-dependent increase in ASQC tumours, although Notch2 deletion is also associated with the MSCC phenotype. This evidence concerns the gene TP53 and neoplasm.